How Sunlink Health Systems (SSY) Stocks Soared With Agios Pharmaceuticals (AGIO), Health Insurance Innovations (HIIQ), Sorrento Therapeutics (SRNE)

Sunlink Health Systems Inc announced that it has completed the sale of substantially all the assets and the leasehold interest of its subsidiary, Dexter Hospital, LLC, to Southeast Health Center of Stoddard County, LLC, an indirect subsidiary of Southeast Missouri Hospital Association (D/B/A SoutheastHEALTH). The assets of Dexter Hospital, LLC consist of a leased 50-bed acute care hospital and related clinics, equipment, and home health services in Dexter, MO. SunLink Health Systems Inc. (SSY), Hospitals company, fostered 5.93% in last trading session and ended the day on $1.25. The stock is trading -57.48% below its 52-week high and 101.61% above its 52-week low. SSY has 3.10x price to cash flow ratio with 0.10% profit margin. Its beta value stands at 1.12 times. The firm has the market capitalization of $11.79 million. SSY showed -28.16% quarterly performance.

Agios Pharmaceuticals, Inc. (AGIO) Saturday reported new clinical data from ongoing Phase 1 study of AG-221, which included 35 patients with IDH2 mutant positive hematologic malignancies. The company said the clinical data continued to show complete and durable remissions in patients with difficult to treat hematologic malignancies. Safety data showed that AG-221 is well tolerated, with the majority of adverse events reported as mild to moderate. Agios Pharmaceuticals, Inc. (AGIO), Biotechnology, is currently trading at $47.50, which gained 5.93%. The stock is trading -4.60% below its 52-week high and 201.20% above its 52-week low. AGIO has $1613.10 million market capitalization. The stock recorded a trading volume of 565462 shares as compared to its average volume of 406.23 million shares. AGIO’s year to date performance is 98.33%. Analysts rate it a ‘Buy’ stock.

Health Insurance Innovations Inc, On April 14, company dismissed its independent registered public accounting firm, Ernst & Young LLP, effective as of that date. On April 14, company selected Grant Thornton LLP as new independent registered public accounting firm, effective immediately. Health Insurance Innovations, Inc. (HIIQ), Health Care Plans company, burgeoned 5.89% in last trading session and ended the day on $10.43. The stock is trading -25.92% below its 52-week high and 24.31% above its 52-week low. Company has 13.74 million shares outstanding with $143.31 million market capitalization. Health Insurance Innovations, Inc. has $0.05 EPS currently and sees 155.70% growth this year and 78.21% next year. HIIQ’s yearly performance is 6.43%. Experts rate it a ‘Buy’ stock.

Sorrento Therapeutics Inc. (SRNE) announced that it has appointed William Marth as Chairman of the Board of Directors. Marth was the President and CEO of Teva – Americas until the end of 2012, and served as a senior advisor to Teva Pharmaceuticals until the end of 2013. Earlier in his career, he held leadership positions in sales and marketing in the Apothecon Division of Bristol-Myers Squibb. Sorrento Therapeutics, Inc. (SRNE), Biotechnology, is currently trading at $5.43, which soared 5.85%. The stock is trading -66.89% below its 52-week high and 14.32% above its 52-week low. Company has 27.83 million shares outstanding with $151.12 million market capitalization. Sorrento Therapeutics, Inc. has -$1.56 EPS currently and sees -247.60% growth this year and 17.40% next year. SRNE’s yearly performance is -47.02%. Trade experts think of it as ‘Buy’ stock.

About

Andy Weld, CFA, is an editor and equity analyst for The Downtown Leader. If you have a great story idea for Andy Weld, you can write at [Andy.Weld@downtownleader.com ].

POST YOUR COMMENTS